Conference abstract · 31 Aug 2018
Conference abstractPublished 21 Nov 2013
Molecular tweezers: Novel protein aggregation inhibitors show promise for treatment and prevention of amyloidoses
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Lysine-specific molecular tweezers are a novel class of compounds that inhibit aberrant protein aggregation and therefore are promising leads for developing therapy for amyloid-related diseases. These compounds utilize a unique process-specific mechanism. They bind to exposed lysines with micromolar affinity and interfere with the combination of hydrophobic and electrostatic interactions that mediate aberrant self-assembly of amyloidogenic proteins. Because the forces that mediate the initial steps in the self-assembly process of these proteins are relatively weak, the labile binding of the molecular tweezers is sufficient to inhibit them. At the same time, this labile binding is not sufficient for interfering with the structure or function of stably folded proteins. Hence, the molecular tweezers become toxic only at concentrations that are orders-of-magnitude higher than those needed for effective inhibition of abnormal protein oligomerization and aggregation. Our lead compound, CLR01, was found to inhibit the aggregation and toxicity of 12 amyloidogenic proteins in vitro, including proteins involved in diverse diseases, such as Alzheimer�s disease, Parkinson�s disease, amyotrophic lateral sclerosis, dialysis-related amyloidosis, systemic amyloidosis, and type-2 diabetes. The compound has shown beneficial effect in six animal models of four different diseases, including Alzheimer�s disease, Parkinson�s disease, and systemic amyloidosis without apparent toxicity and thus shows great potential as a broad-spectrum inhibitor of diseases caused by protein misfolding and aggregation.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 31 Aug 2018
Prevention and Treatment of Alzheimer’s Disease and other Neurodegenerative Disorders by Inhibition of Protein Misfolding and Aggregation
Article · 26 Jun 2024
Neurodegenerative Disorders and Protein Aggregation: Unraveling the Molecular Tangles
Conference abstract · 10 Aug 2023
Investigating a Novel Drug – A Promising Breakthrough in the Prevention of Alzheimer’s Disease.
Conference abstract · 17 Sep 2018
Synthesis of novel nucleos(t)ide analogs as promising lead molecules for the symptomatic treatment of Alzheimers disease
More from this journal
The newest in Journal of Alzheimers Disease & Parkinsonism.
Commentary · 8 Jun 2026
Cognitive Concerns: The Side Effects of Surgery in Alzheimer's Patients
Perspective · 8 Jun 2026
Oxidative Stress and Its Role in Neuronal Degeneration: Mechanisms and Implications
Commentary · 8 Jun 2026
Understanding the Pathophysiology of Prion-Induced Dementia
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Alzheimers Disease & Parkinsonism
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Gal Bitan”
